Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects

Mise à jour : Il y a 4 ans
Référence : NCT00481481

Femme et Homme

Extrait

Assessment of the safety and the efficacy of a tacrolimus modified release (FK506MR) based immunosuppressive regimen in stable kidney transplant subjects converted from a cyclosporin based immunosuppressive regimen.


Critère d'inclusion

  • Transplantation


Liens